Analgesics - Benelux | Statista Market Forecast

Revenue in the Analgesics market in Benelux amounts to US$351.30m in 2024.
The market is expected to grow annually by 4.67% (CAGR 2024-2029).
In global comparison, most revenue is generated the United States (US$7.24bn in 2024).
In relation to the total population figures, per person revenues of US$11.69 are generated in 2024.
The Benelux region is witnessing a growing demand for natural and herbal analgesics, as consumers prioritize non-chemical alternatives for pain relief.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Benelux continues to grow steadily, driven by customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Analgesics market in Benelux are influenced by several factors. First, consumers in the region prioritize convenience and ease of use when it comes to pain relief. This has led to a growing demand for over-the-counter analgesics that are readily available in pharmacies and supermarkets. Additionally, consumers in Benelux value products that provide fast and effective pain relief without causing any significant side effects. As a result, there is a preference for analgesics that are known for their safety and efficacy.Trends in the Analgesics market in Benelux are also shaping its development. One notable trend is the increasing popularity of natural and herbal remedies for pain relief. Consumers are becoming more conscious of the ingredients in the products they use and are seeking out natural alternatives to traditional analgesics. This trend is driving the growth of herbal analgesics and supplements in the market.Another trend in the market is the rising demand for specialized analgesics targeting specific types of pain, such as migraines or joint pain. Manufacturers are responding to this demand by developing and marketing products that address these specific pain conditions. This trend is driven by the increasing prevalence of chronic pain conditions in the region and the desire for targeted relief.Local special circumstances in Benelux also play a role in the development of the Analgesics market. The region has a well-established healthcare system with easy access to healthcare professionals and pharmacies. This accessibility contributes to the high demand for analgesics, as consumers can easily seek advice and purchase products to manage their pain. Additionally, the aging population in Benelux is driving the demand for analgesics, as older individuals are more likely to experience chronic pain and require pain management solutions.Underlying macroeconomic factors also contribute to the growth of the Analgesics market in Benelux. The region has a stable and prosperous economy, which allows consumers to afford healthcare products, including analgesics. Furthermore, the increasing awareness and focus on health and well-being in society are driving the demand for analgesics as consumers prioritize their physical comfort and pain management.In conclusion, the Analgesics market in Benelux is developing due to customer preferences for convenience and efficacy, trends in the market such as the popularity of natural remedies and specialized analgesics, local special circumstances including the accessibility of healthcare and the aging population, and underlying macroeconomic factors such as a stable economy and increasing health consciousness.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.